← Back to patent-cliff list
盐酸利多卡因
Tier C — Watch / tradeLidocaine Hydrochloride
费森尤斯卡比股份有限公司
Originator
1948
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：SCNA
Brand：Xylocaine Dental、Xylocaine Preservative Free、Zingo、Akten、Lidopen、Xylocaine Viscous、Xylocaine
Indications (approved)：心律失常、麻醉、室性心动过速
Regional status
US
批准上市
1948-11-19
EU
临床三期
2021-01-01
China
批准上市
1976-01-01
Japan
批准上市
1955-12-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Lidocaine Hydrochloride?
Approved indications include: 心律失常, 麻醉, 室性心动过速.
When does the Lidocaine Hydrochloride patent expire?
No public expiry year is available for Lidocaine Hydrochloride yet; this page updates once verified.
How do I get a quote for Lidocaine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25